Autopsy report · NCT02408458

Miromatrix Biological Mesh for Ventral Hernia Repair

“enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Miromatrix Medical Inc.

Sponsor type

Industry

Conditions

Ventral Hernia

Interventions

MIROMESH®

Participants

0

Sites

4

Countries

United States

Trials that died the same way

• Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
  “Low enrollment rate” (85% match in meaning)
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (83% match in meaning)
• Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
  “Lower than anticipated rate of subject enrollment” (81% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (80% match in meaning)
• Development of a NIPTT for Detecting Copy Number Variations
  “Poor rate of eligible subject enrollment” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.